Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Troubling differences in the success rates of breast cancer treatment across different countries

EBCC 9

19 - 21 Mar 2014

Published: 4 Apr 2014

Views: 3033

Rating:

Save

Dr Philippe Autier - International Prevention Research Unit, Lyons, France

At a press conference during the EBCC, Dr Autier discussed the differences in survival rates among breast cancer patients of different countries.

Read the article or watch the interview for a deeper look.

Related Videos

Advancing breast cancer diagnosis in the developing world

Dr Hans Junkermann, Prof Dr.Erkin Arıbal and Dr Richard Rainsbury

Advancing breast cancer diagnosis in the developing world ( Dr Hans Junkermann, Prof Dr.Erkin Arıbal and Dr Richard Rainsbury )

Rationale for routine use of IORT for early breast cancer and data for specific...

Dr Hans-Christian Kolberg - Marienhospital Bottrop gGmbH, Bottrop, Germany

Rationale for routine use of IORT for early breast cancer and data for specific indications ( Dr Hans-Christian Kolberg - Marienhospital Bottrop gGmbH, Bottrop, Germany )

Global adoption of single-shot targeted IORT for breast cancer

Dr Jayant Vaidya - University College London, London, UK

Global adoption of single-shot targeted IORT for breast cancer ( Dr Jayant Vaidya - University College London, London, UK )

IORT at University Hospital Augsburg in Germany

Dr Klaus-Henning Kahl - University Hospital Augsburg, Augsburg, Germany

IORT at University Hospital Augsburg in Germany ( Dr Klaus-Henning Kahl - University Hospital Augsburg, Augsburg, Germany )

IORT at Fortis Hospital Bangalore in India

Dr Sandeep Nayak - Fortis Hospital, Bangalore, India

IORT at Fortis Hospital Bangalore in India ( Dr Sandeep Nayak - Fortis Hospital, Bangalore, India )

Updates on HER2-low breast cancer

Prof Sana Al Sukhun - University of Jordan, Amman, Jordan

Updates on HER2-low breast cancer ( Prof Sana Al Sukhun - University of Jordan, Amman, Jordan )

Lymph node irradiation therapy for BC in the 21st Century

Prof Philip Poortmans - University of Antwerp, Antwerp, Belgium

Lymph node irradiation therapy for BC in the 21st Century ( Prof Philip Poortmans - University of Antwerp, Antwerp, Belgium )

Novel antibody-drug conjugates (ADCs) technologies for management of mBC

Prof Hope Rugo - University of California San Francisco, San Francisco, USA

Novel antibody-drug conjugates (ADCs) technologies for management of mBC ( Prof Hope Rugo - University of California San Francisco, San Francisco, USA )

COMMENT: Women Who Conquer Cancer

Prof Ahlam Dohal - King Fahd Specialised Hospital Dammam, Dammam, Saudi Arabia

COMMENT: Women Who Conquer Cancer ( Prof Ahlam Dohal - King Fahd Specialised Hospital Dammam, Dammam, Saudi Arabia )

More from ecancer